CRH
CRH
Market cap $64.1B

95.24 USD

-0.65

0.68%

At close Jul 11, 4:00 PM EDT

After hours

95.24

+0.00

0.00%

1 day

-0.68%

5 days

0.16%

1 month

4.57%

3 months

12.39%

6 months

4.03%

Year to date

2.73%

1 year

19.63%

5 years

166.11%

10 years

230.58%

About: CRH is a global manufacturer of a range of building products used in construction projects, operating via a vertically integrated business model. The past decade has seen CRH transform into a leading building materials business, with increasing exposure to upstream building activities such as aggregates and cement. CRH's geographic footprint is mostly across developed markets. North America is CRH's largest market and accounts for 75% of EBITDA. The company is the largest producer of aggregates and asphalt in the US.

Employees: 79,800

Materials Building Materials

0

Funds holding %

of 7,312 funds

–

Analysts bullish %

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

854% more call options, than puts

Call options by funds: $1.05B | Put options by funds: $110M

61% more first-time investments, than exits

New positions opened: 134 | Existing positions closed: 83

15% more repeat investments, than reductions

Existing positions increased: 342 | Existing positions reduced: 298

4% more funds holding

Funds holding: 822 [Q4 2024] → 852 (+30) [Q1 2025]

2.33% more ownership

Funds ownership: 77.33% [Q4 2024] → 79.65% (+2.33%) [Q1 2025]

2% less capital invested

Capital invested by funds: $48.6B [Q4 2024] → $47.4B (-$1.18B) [Q1 2025]

4% less funds holding in top 10

Funds holding in top 10: 50 [Q4 2024] → 48 (-2) [Q1 2025]

See Fund Rankings

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

$105

10%

upside

Avg. target

$107

12%

upside

High target

$108

13%

upside

2 analyst ratings

1 positive

50%

1 neutral

50%

0 negative

0%

DA Davidson Brent Thielman	10%upside $105	Neutral Downgraded	10 Jul 2025
RBC Capital Anthony Codling	13%upside $108	Outperform Maintained	14 Apr 2025

See Analyst Rankings

Financial journalist opinion

Based on 4 articles about CRH published over the past 30 days

Zacks Investment Research

CRH (CRH) Laps the Stock Market: Here's Why

CRH (CRH) closed at $96.47 in the latest trading session, marking a +1.92% move from the prior day.

CRH (CRH) Laps the Stock Market: Here's Why

Top 10 High-Yield Dividend Stocks For July 2025

My July 2025 watchlist focuses on high-yield, attractively valued stocks, aiming for a 12% long-term CAGR and outperforming benchmarks. Since its inception, my watchlist has a CAGR of 15.11%, performing in-line with SPY and VYM, while providing a superior dividend yield. The June 2025 watchlist includes 10 stocks with an average forward dividend yield of 3.54% and an expected return of 13.62%.

Top 10 High-Yield Dividend Stocks For July 2025

CRH to Host Investor Day on September 30th 2025

NEW YORK--(BUSINESS WIRE)--CRH (NYSE: CRH), the leading provider of building materials solutions, will hold an in-person investor event in New York City on Tuesday, September 30, 2025, hosted by CEO, Jim Mintern, and the executive leadership team. The event will also be broadcast via webcast and registration details will be made available on crh.com. About CRH CRH plc (NYSE: CRH) is the leading provider of building materials solutions that build, connect and improve our world. Employing 80,000.

CRH to Host Investor Day on September 30th 2025

Zacks Investment Research

CRH (CRH) Laps the Stock Market: Here's Why

In the latest trading session, CRH (CRH) closed at $91.52, marking a +1.77% move from the previous day.

CRH (CRH) Laps the Stock Market: Here's Why

CRH Medical Corporation and WovenX Announce Strategic Partnership to Advance GI Patient Access and Streamline Care Delivery

ATLANTA & CHICAGO--(BUSINESS WIRE)--CRH Medical Corporation (“CRH”), a leading provider of products and services for gastrointestinal (GI) providers and a wholly owned subsidiary of WELL Health Technologies Corp. (“WELL”), has announced a strategic partnership with WovenX Health (“WovenX”), a leader in integrated virtual specialty care. Together, they aim to deliver integrated, next-generation GI practice solutions designed to resolve persistent challenges surrounding patient access and operati.

CRH Medical Corporation and WovenX Announce Strategic Partnership to Advance GI Patient Access and Streamline Care Delivery

CRH Stock Falls Despite Solid Earings. Nothing Bad Has Happened—Yet.

Investors can take some solace in the outlook from construction giant CRH. It isn't seeing any negative impact from macroeconomic uncertainty yet.

CRH Stock Falls Despite Solid Earings. Nothing Bad Has Happened—Yet.

CRH plc (CRH) Q1 2025 Earnings Call Transcript

CRH plc (NYSE:CRH ) Q1 2025 Earnings Conference Call May 6, 2025 8:00 AM ET Company Participants Conference Call Participants Operator Good day, and welcome to the CRH First Quarter 2025 Results Presentation. My name is Christa, and I will be your operator today.

CRH plc (CRH) Q1 2025 Earnings Call Transcript

Zacks Investment Research

CRH (CRH) Reports Q1 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for CRH (CRH) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

CRH (CRH) Reports Q1 Earnings: What Key Metrics Have to Say

CRH plc (the "Company") Form 10-Q for the quarterly period ended March 31, 2025

NEW YORK--(BUSINESS WIRE)--A Form 10-Q for the quarterly period ended March 31, 2025 (the “Form 10-Q”) has been filed with the U.S. Securities and Exchange Commission (the "SEC") today. The Form 10-Q is available to view on the SEC's website at: https://www.sec.gov. and the Company's website at: https://www.crh.com.

CRH plc (the "Company") Form 10-Q for the quarterly period ended March 31, 2025

CRH Continues Share Buyback Program

NEW YORK--(BUSINESS WIRE)--CRH (NYSE: CRH), the leading provider of building materials solutions, is pleased to announce that it has completed the latest phase of its share buyback program, returning a further $0.3 billion of cash to shareholders. Between February 27, 2025 and May 2, 2025, 3.3 million ordinary shares listed on the New York Stock Exchange were repurchased. This brings total cash returned to shareholders under our ongoing share buyback program to $8.8 billion since its commenceme.

CRH Continues Share Buyback Program

See News Rankings

Charts implemented using Lightweight Charts™